Role of HNF-1α and NHF-1β on insulin, IGF-1 and other potential target genes

Expert Review of Endocrinology and Metabolism

Volumn 3, Issue 4, 2008, Pages 441-452

  Kitanaka, Sachiko ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Diabetes mellitus; Hepatocyle nuclear factor 1 ; Hepatocyle nuclear factor 1 ; IGF 1; Insulin; Maturity onset diabetes of the young; Transcription factor

Indexed keywords

CHOLESTEROL 7ALPHA MONOOXYGENASE; DIPEPTIDYL PEPTIDASE IV; FARNESOID X RECEPTOR; FARNESOID X RECEPTOR 1; FIBROCYSTIN; GENE PRODUCT; GLUCOSE TRANSPORTER 2; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MULTIDRUG RESISTANCE PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTING POLYPEPTIDE; POLYCYSTIN 2; PROTEIN NEURO BETA 2; PROTEIN UMOD; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UVOMORULIN;

CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; DIABETOGENESIS; DNA MODIFICATION; FANCONI RENOTUBULAR SYNDROME; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERBILIRUBINEMIA; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN SYNTHESIS; LIVER DYSFUNCTION; MATURITY ONSET DIABETES MELLITUS; MATURITY ONSET DIABETES OF THE YOUNG 3; MATURITY ONSET DIABETES OF THE YOUNG 5; MICROARRAY ANALYSIS; MORTALITY; NONHUMAN; PHENOTYPE; PHENYLKETONURIA; POSTNATAL GROWTH; PRENATAL GROWTH; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION;

EID: 55649098550     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/17446651.3.4.441     Document Type: Review

References (137)

1. Courtois C, Morgan JG, Campbell LA, Fourel G, Crabtree CR. Interaction of a liver-specific nuclear factor with the fibrinogen and α-1-antitrypsin promoters. Science 238(4827), 688-692 (1987).
2. Cereghini S, Blumenfeld M, Yaniv M. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev. 2(8), 957-974 (1988).
3. Hardon E, Frain M, Paonessa G, Cortese R. Two distinct factors interact with the promoter regions of several liver-specific genes. EMBO J. 7(6), 1711-1719 (1988).
4. Frain M, Swart G, Monaci P et al. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 59(1), 145-157 (1989).
5. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10(2), 267-282 (1996).
6. Rey-Campos J, Chouard T, Yaniv M, Cereghini S. vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1. EMBO J. 10(6), 1445-1457 (1991).
7. De Simone V, De Magistris L, Lazzaro D et al. LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia. EMBO J. 10(6), 1435-1443 (1991).
8. Mendel D, Hansen L, Graves M, Conley P, Crabtree G. HNF-1α and HNF-1β (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev. 5(6), 1042-1056 (1991).
9. Nicosia A, Monaci P, Tomei L et al. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 61(7), 1225-1236 (1990).
10. Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res. 18(19), 5853-5863 (1990).
11. Toniatti C, Monaci P, Nicosia A, Cortese R, Ciliberto G. A bipartite activation domain is responsible for the activity of transcription factor HNF1/LFB1 in cells of hepatic and nonhepatic origin. DNA Cell Biol. 12(3), 199-208 (1993).
12. Tronche F, Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 14(9), 579-587 (1992).
13. Mendel D, Khavari P, Conley P et al. Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. Science 254(5039), 1762-1767 (1991).
14. Soutoglou E, Papafotiou G, Katrakili N, Talianidis I. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J. Biol. Chem. 275(17), 12515-12520 (2000).
15. Ban N, Yamada Y, Someya Y et al. Hepatocyte nuclear factor-1α recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 51(5), 1409-1418 (2002).
16. Barbacci E, Chalkiadaki A, Masdeu C et al. HNF1β/TCF2 mutations impair transactivation potential through altered co-regulator recruitment. Hum. Mol. Genet. 13(24), 3139-3149 (2004).
17. Kuo C, Conley P, Hsieh C, Francke U, Crabtree G. Molecular cloning, functional expression, and chromosomal localization of mouse hepatocyte nuclear factor 1. Proc. Natl Acad. Sci. USA 87(24), 9838-9842 (1990).
18. Ott M, Rey-Campos J, Cereghini S, Yaniv M. vHNF1 is expressed in epithelial cells of distinct embryonic origin during development and precedes HNF1 expression. Mech. Dev. 36(1-2), 47-58 (1991).
19. Lazzaro D, De Simone V, De Magistris L, Lehtonen E, Cortese R. LFB1 and LFB3 homeoproteins are sequentially expressed during kidney development. Development 114(2), 469-479 (1992).
20. Cereghini S, Ott M, Power S, Maury M. Expression patterns of vHNF1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles. Development 116(3), 783-797 (1992).
21. Coffinier C, Barra J, Babinet C, Yaniv M. Expression of the vHNF1/ HNF1β homeoprotein gene during mouse organogenesis. Mech. Dev. 89(1-2), 211-213 (1999).
22. Haumaitre C, Barbacci E, Jenny M, Ott M, Gradwohl G, Cereghini S. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc. Natl Acad. Sci. USA 102(5), 1490-1495 (2005).
23. Nammo T, Yamagata K, Hamaoka R et al. Expression profile of MODY3/ HNF-1α protein in the developing mouse pancreas. Diabetologia 45(8), 1142-1153 (2002).
24. Maestro M, Boj S, Luco R et al. Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Hum. Mol. Genet. 12(24), 3307-3314 (2003).
25. Nammo T, Yamagata K, Tanaka T et al. Expression of HNF-4α (MODY1), HNF-1β (MODY5), and HNF-1α (MODY3) proteins in the developing mouse pancreas. Gene Expr. Patterns 8(2), 96-106 (2008).
26. Welters H, Senkel S, Klein-Hitpass L et al. Conditional expression of hepatocyte nuclear factor-1β, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic β-cells. J. Endocrinol. 190(1), 171-181 (2006).
27. Pontoglio M, Barra J, Hadchouel M et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84(4), 575-585 (1996).
28. Pontoglio M, Sreenan S, Roe M et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J. Clin. Invest. 101(10), 2215-2222 (1998).
29. Lee Y, Sauer B, Gonzalez F. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse. Mol. Cell. Biol. 18(5), 3059-3068 (1998).
30. Shih D, Bussen M, Sehayek E et al. Hepatocyte nuclear factor-1α is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27(4), 375-382 (2001).
31. Barbacci E, Reber M, Ott M, Breillat C, Huetz F, Cereghini S. Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development 126(21), 4795-4805 (1999).
32. Coffinier C, Thépot D, Babinet C, Yaniv M, Barra J. Essential role for the homeoprotein vHNF1/HNF1β in visceral endoderm differentiation. Development 126(21), 4785-4794 (1999).
33. Wang L, Coffinier C, Thomas M et al. Selective deletion of the Hnf1β (MODY5) gene in β-cells leads to altered gene expression and defective insulin release. Endocrinology 145(8), 3941-3949 (2004).
34. Coffinier C, Gresh L, Fiette L et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1β. Development 129(8), 1829-1838 (2002).
35. Gresh L, Fischer E, Reimann A et al. A transcriptional network in polycystic kidney disease. EMBO J. 23(7), 1657-1668 (2004).
36. Sun Z, Hopkins N. vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain. Genes Dev. 15(23), 3217-3229 (2001).
37. Bagnat M, Cheung I, Mostov K, Stainier D. Genetic control of single lumen formation in the zebrafish gut. Nat. Cell Biol. 9(8), 954-960 (2007).
38. Vignali R, Poggi L, Madeddu F, Barsacchi G. HNF1(β) is required for mesoderm induction in the Xenopus embryo. Development 127(7), 1455-1465 (2000).
39. Aragón F, Vázquez-Echeverría C, Ulloa E et al. vHnf1 regulates specification of caudal rhombomere identity in the chick hindbrain. Dev. Dyn. 234(3), 567-576 (2005).
40. Fajans S, Bell G, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345(13), 971-980 (2001).
41. Ryffel G. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J. Mol. Endocrinol. 27(1), 11-29 (2001).
42. Yamagata K, Oda N, Kaisaki P et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 384(6608), 455-458 (1996).
43. Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat. Genet. 17(4), 384-385 (1997).
44. Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384(6608), 458-460 (1996).
45. Stoffers D, Zinkin N, Stanojevic V, Clarke W, Habener J. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15(1), 106-110 (1997).
46. Malecki M, Jhala U, Antonellis A et al. Mutations in NEUROD1 are associated with the development of Type 2 diabetes mellitus. Nat. Genet. 23(3), 323-328 (1999).
47. Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328(10), 697-702 (1993).
48. Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1α (HNF1A) and 4α (HNF4A) in maturity-onset diabetes of the young. Hum. Mutat. 27(9), 854-869 (2006).
49. Byrne M, Sturis J, Menzel S et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45(11), 1503-1510 (1996).
50. Lehto M, Tuomi T, Mahtani M et al. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J. Clin. Invest. 9(4), 582-591 (1997).
51. Frayling T, Evans J, Bulman M et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50(Suppl. 1), S94-S100 (2001).
52. Yamada S, Nishigori H, Onda H et al. Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene in Japanese subjects with IDDM. Diabetes 46(10), 1643-1647 (1997).
53. Pearson E, Starkey B, Powell R, Gribble F, Clark P, Hattersley A. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362(9392), 1275-1281 (2003).
54. Shepherd M, Pearson E, Houghton J, Salt G, Ellard S, Hattersley A. No deterioration in glycemic control in HNF-1α maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 26(11), 3191-3192 (2003).
55. Bingham C, Bulman M, Ellard S et al. Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease. Am. J. Hum. Genet. 68(1), 219-224 (2001).
56. Kolatsi-Joannou M, Bingham C, Ellard S et al. Hepatocyte nuclear factor-1β: a new kindred with renal cysts and diabetes and gene expression in normal human development. J. Am. Soc. Nephrol. 12(10), 2175-2180 (2001).
57. Bingham C, Ellard S, Cole T et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1β mutations. Kidney Int. 61(4), 1243-1251 (2002).
58. Bingham C, Ellard S, van't Hoff W et al. Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1β gene mutation. Kidney Int. 63(5), 1645-1651 (2003).
59. Bingham C, Hattersley A. Renal cysts and diabetes syndsome resulting from mutations in hepatocyte nuclear factor-1β. Nephrol. Dial. Transplant. 19(11), 2703-2708 (2004).
60. Kitanaka S, Miki Y, Hayashi Y, Igarashi T. Promoter-specific repression of hepatocyte nuclear factor (HNF)-1β and HNF-1α transcriptional activity by an HNF-1β missense mutant associated with Type 5 maturity-onset diabetes of the young with hepatic and biliary manifestations. J. Clin. Endocrinol. Metab. 89(3), 1369-1378 (2004).
61. Bellanné-Chantelot C, Chauveau D, Gautier J et al. Clinical spectrum associated with hepatocyte nuclear factor-1β mutations. Ann. Intern. Med. 140(7), 510-517 (2004).
62. Edghill E, Bingham C, Ellard S, Hattersley A. Mutations in hepatocyte nuclear factor-1β and their related phenotypes. J. Med. Genet. 43(1), 84-90 (2006).
63. Ulinski T, Lescure S, Beaufils S et al. Renal phenotypes related to hepatocyte nuclear factor-1β (TCF2) mutations in a pediatric cohort. J. Am. Soc. Nepbrol. 17(2), 497-503 (2006).
64. Weber S, Moriniere V, Knüppel T et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J. Am. Soc. Nephrol. 17(10), 2864-2870 (2006).
65. Decramer S, Parant O, Beaufils S et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J. Am. Soc. Nephrol. 18(3), 923-933 (2007).
66. Bellanné-Chantelot C, Clauin S, Chauveau D et al. Large genomic rearrangements in the hepatocyte nuclear factor-1β (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54(11), 3126-3132 (2005).
67. Edghill E, Bingham C, Slingerland A et al. Hepatocyte nuclear factor-β mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1β in human pancreatic development. Diabet. Med. 23(12), 1301-1306 (2006).
68. Lindner T, Njolstad P, Horikawa Y, Bostad L, Bell G, Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1β. Hum. Mol. Genet. 8(11), 2001-2008 (1999).
69. Bingham C, Ellard S, Allen L et al. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β. Kidney Int. 57(3), 898-907 (2000).
70. Furuta H, Furuta M, Sanke T et al. Nonsense and missense mutations in the human hepatocyte nuclear factor-1β gene (TCF2) and their relation to Type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab. 87(8), 3859-3863 (2002).
71. Pearson E, Badman M, Lockwood C et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1α and -1β mutations. Diabetes Care 27(5), 1102-1107 (2004).
72. Brackenridge A, Pearson E, Shojaee-Moradie F, Hattersley A, Russell-Jones D, Umpleby A. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1β and -1α mutations. Diabetes 55(2), 405-411 (2006).
73. Haumaitre C, Fabre M, Cormier S, Baumann C, Delezoide A, Cereghini S. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1β/MODY5 mutations. Hum. Mol. Genet. 15(15), 2363-2375 (2006).
74. Hattersley A, Pearson E. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, β-cell physiology, and genetics in diabetes. Endocrinology 147(6), 2657-2663 (2006).
75. Wild W, Pogge von Strandmann E, Nastos A et al. The mutated human gene encoding hepatocyte nuclear factor 1β inhibits kidney formation in developing Xenopus embryos. Proc. Natl Acad. Sci. USA 97(9), 4695-4700 (2000).
76. Bohn S, Thomas H, Turan G et al. Distinct molecular and morphogenetic properties of mutations in the human HNF1β gene that lead to defective kidney development. J. Am. Soc. Nephrol. 14(8), 2033-2041 (2003).
77. Yoshiuchi I, Yamagata K, Zhu Q et al. Identification of a gain-of-function mutation in the HNF-1β gene in a Japanese family with MODY. Diabetologia 45(1), 154-155 (2002).
78. Thomas H, Senkel S, Erdmann S et al. Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4α and HNF1β in a pancreatic β-cell line. Nucleic Acids Res. 32(19), e150 (2004).
79. Kitanaka S, Sato U, Igarashi T. Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1β and HNF-1α and the abnormality of HNF-1β mutants. J. Endocrinol. 192(1), 141-147 (2007).
80. Bellanné-Chantelot C, Carette C, Riveline J et al. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 57(2), 503-508 (2008).
81. Edghill E, Oram R, Owens M et al. Hepatocyte nuclear factor-1 {β} gene deletions - a common cause of renal disease. Nephrol. Dial. Transplant. 23(2), 627-635 (2008).
82. Carette C, Vaury C, Barthélémy A et al. Exonic duplication of the hepatocyte nuclear factor-1β gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J. Clin. Endocrinol. Metab. 92(7), 2844-2847 (2007).
83. Ellard S, Thomas K, Edghil E et al. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia 50(11), 2313-2317 (2007).
84. Wang H, Maechler P, Hagenfeldt K, Wollheim C. Dominant-negative suppression of HNF-1α function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic β-cell line. EMBO J. 17(22), 6701-6713 (1998).
85. Guillam M, Hümmler E, Schaerer E et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet. 17(3), 327-330 (1997).
86. Shih D, Screenan S, Munoz K et al. Loss of HNF-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50(11), 2472-2480 (2001).
87. Yamagata K, Nammo T, Moriwaki M et al. Overexpression of dominant-negative mutant hepatocyte nuclear factor-1α in pancreatic β-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced β-cell proliferation, and diabetes. Diabetes 51(1), 114-123 (2002).
88. Hagenfeldt-Johansson K, Herrera P, Wang H, Gjinovci A, Ishihara H, Wollheim C. β-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1α induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology 142(12), 5311-5320 (2001).
89. Wang H, Antinozzi P, Hagenfeldt K, Maechler P, Wollheim C. Molecular targets of a human HNF1α mutation responsible for pancreatic β-cell dysfunction. EMBO J. 19(16), 4257-4264 (2000).
90. Akpinar P, Kuwajima S, Krützfeldt J, Stoffel M. Tmem27: a cleaved and shed plasma membrane protein that stimulates pancreatic β cell proliferation. Cell Metab. 2(6), 385-397 (2005).
91. Fukui K, Yang Q, Cao Y et al. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metab. 2(6), 373-384 (2005).
92. Yamagata K, Nammo T, Sato Y, Saisho K, Shoda H, Fukui K. The HNF-1α-SNARE connection. Diabetes Obes. Metab. 9(Suppl. 2), 40-45 (2007).
93. Gu N, Suzuki N, Takeda J et al. Effect of mutations in HNF-1α and HNF-1β on the transcriptional regulation of human sucrase-isomaltase in Caco-2 cells. Biochem. Biophys. Res. Commun. 325(1), 308-313 (2004).
94. Gu N, Adachi T, Matsunaga T et al. Mutant HNF-1α and mutant HNF-1β identified in MODY3 and MODY5 downregulate DPP-IV gene expression in Caco-2 cells. Biochem. Biophys, Res. Commun. 346(3), 1016-1023 (2006).
95. Senkel S, Lucas B, Klein-Hitpass L, Ryffel G. Identification of target genes of the transcription factor HNF1β and HNF1α in a human embryonic kidney cell line. Biochim. Biophys. Acta 1731(3), 179-190 (2005).
96. Hay C, Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes 55(12), 3201-3213 (2006).
97. Furukawa N, Shirotani T, Nakamaru K, Matsumoto K, Shichiri M, Araki E. Regulation of the insulin gene transcription by glucose. Endocr. J. 49(2), 121-130 (2002).
98. Emens L, Landers D, Moss L. Hepatocyte nuclear factor 1α is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc. Natl Acad. Sci. USA 89(16), 7300-7304 (1992).
99. Okita K, Yang Q, Yamagata K et al. Human insulin gene is a target gene of hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β. Biochem. Biophys. Res. Commun. 263(2), 566-569 (1999).
100. Lee J, Ristow M, Lin X, White M, Magnuson M, Hennighausen L. RIP-Cre revisited, evidence for impairments of pancreatic β-cell function. J. Biol. Chem. 281(5), 2649-2653 (2006).
101. Fujimoto K, Sasaki T, Hiki Y et al. In vitro and pathological investigations of MODY5 with the R276X-HNF1β (TCF2) mutation. Endocr. J. 54(5), 757-764 (2007).
102. Poll A, Pierreux C, Lokmane L et al. A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells. Diabetes 55(1), 61-69 (2006).
103. Baker J, Liu J, Robertson E, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75(1), 73-82 (1993).
104. Liu J, Baker J, Perkins A, Robertson E, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75(1), 59-72 (1993).
105. Woods K, Camacho-Hübner C, Savage M, Clark A. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 335(18), 1363-1367 (1996).
106. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr. Rev. 22(6), 818-835 (2001).
107. Nolten L, Steenbergh P, Sussenbach J. Hepatocyte nuclear factor 1α activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol. Endocrinol. 9(11), 1488-1499 (1995).
108. Kulik V, Kavsan V, van Schaik F, Nolten L, Steenbergh P, Sussenbach J. The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor 1. J. Biol. Chem. 270(3), 1068-1073 (1995).
109. Hügl S, White M, Rhodes C. Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J. Biol. Chem. 273(28), 17771-17779 (1998).
110. Guo Y, Lu Y, Houle D et al. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology 146(6), 2602-2609 (2005).
111. Yang Q, Yamagata K, Fukui K et al. Hepatocyte nuclear factor-1α modulates pancreatic β-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes 51(6), 1785-1792 (2002).
112. Maher J, Slitt A, Callaghan T et al. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1α. Biochem. Pharmacol. 72(4), 512-522 (2006).
113. Kikuchi R, Kusuhara H, Hattori N et al. Regulation of tissue-specific expression of the human and mouse urate transporter 1 gene by hepatocyte nuclear factor 1α/β and DNA methylation. Mol. Pharmacol. 72(6), 1619-1625 (2007).
114. Odom D, Zizlsperger N, Gordon D et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303(5662), 1378-1381 (2004).
115. Odom D, Dowell R, Jacobsen E et al. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat. Genet. 39(6), 730-732 (2007).
116. Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes 51(8), 2355-2362 (2002).
117. Hiesberger T, Bai Y, Shao X et al. Mutation of hepatocyte nuclear factor-1β inhibits Pkhd1 gene expression and produces renal cysts in mice. J. Clin. Invest. 113(6), 814-825 (2004).
118. Zhang Y, Wada J, Yasuhara A et al. The role for HNF-1β-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS ONE 2(5), e414 (2007).
119. Rebouissou S, Vasiliu V, Thomas C et al. Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum. Mol. Genet. 14(5), 603-614 (2005).
120. Ma Z, Gong Y, Patel V et al. Mutations of HNF-1β inhibit epithelial morphogenesis through dysregulation of SOCS-3. Proc. Natl Acad. Sci. USA 104(51), 20386-20391 (2007).
121. Iwasaki N, Ogata M, Tomonaga O et al. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care 21(12), 2144-2148 (1998).
122. Montoli A, Colussi G, Massa O et al. Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1β gene: description of a new family with associated liver involvement. Am. J. Kidney Dis. 40(2), 397-402 (2002).
123. Beckers D, Bellanné-Chantelot C, Maes M. Neonatal cholestatic jaundice as the first symptom of a mutation in the hepatocyte nuclear factor-1β gene (HNF-1β). J. Pediatr. 150(3), 313-314 (2007).
124. Boudreau F, Zhu Y, Traber P. Sucrase-isomaltase gene transcription requires the hepatocyte nuclear factor-1 (HNF-1) regulatory element and is regulated by the ratio of HNF-1α to HNF-1β. J. Biol. Chem. 276(34), 32122-32128 (2001).
125. Song Y, Ray K, Liebhaber S, Cooke N. Vitamin D-binding protein gene transcription is regulated by the relative abundance of hepatocyte nuclear factors 1α and 1β. J. Biol. Chem. 273(43), 28408-28418 (1998).
126. Párrizas M, Maestro M, Boj S et al. Hepatic nuclear factor 1-α directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol. Cell. Biol. 21(9), 3234-3243 (2001).
127. Luco R, Maestro M, del Pozo N, Philbrick W, de La Ossa P, Ferrer J. A conditional model reveals that induction of hepatocyte nuclear factor-1α in Hnf1α-null mutant β-cells can activate silenced genes postnatally, whereas overexpression is deleterious. Diabetes 55(8), 2202-2211 (2006).
128. Winckler W, Burtt N, Holmkvist J et al. Association of common variation in the HNF1α gene region with risk of Type 2 diabetes. Diabetes 54(8), 2336-2342 (2005).
129. Weedon M, Owen K, Shields B et al. A large-scale association analysis of common variation of the HNF1α gene with Type 2 diabetes in the U.K. Caucasian population. Diabetes 54(8), 2487-2491 (2005).
130. Gudmundsson J, Sulem P, Rafnar T et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat. Genet. 40(3), 281-283 (2008).
131. Furihata T, Satoh T, Yamamoto N, Kobayashi K, Chiba K. Hepatocyte nuclear factor 1α is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers. Pharm. Res. 24(12), 2327-2332 (2007).
132. Bluteau O, Jeannot E, Bioulac-Sage P et al. Bi-allelic inactivatinn of TCF1 in hepatic adenomas, Nat. Genet. 32(2), 312-315 (2002).
133. Terasawa K, Toyota M, Sagae S et al. Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. Br. J. Cancer 94(6), 914-921 (2006).
134. Fischer E, Legue E, Doyen A et al. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38(1), 21-23 (2006).
135. Boj S, Parrizas M, Maestro M, Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc. Natl Acad. Sci. USA 98(25), 14481-14486 (2001).
136. Hansen S, Párrizas M, Jensen M et al. Genetic evidence that HNF-1α-dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. J. Clin. Invest. 110(6), 827-833 (2002).
137. Thomas H, Jaschkowitz K, Bulman M et al. A distant upstream promoter of the HNF-4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet. 10(19), 2089-2097 (2001).